As cardiometabolic diseases, such as Type 2 diabetes and obesity, continue to rise globally, the healthcare industry faces unprecedented challenges. According to the World Health Organization (WHO), more than one billion people are affected by obesity, an alarming figure that spurred the coining of the term “globesity.” Obesity is not only a significant health issue…
Becton, Dickinson and Co. (BD) has evolved from a syringe manufacturer into a leading MedTech company, driving digital transformation in healthcare with solutions like automated pharmacy systems that improve efficiency and patient outcomes. In Taiwan, BD’s innovations align with the government’s “Healthy Taiwan” initiative, as the country aims to establish itself as a MedTech hub. Despite Taiwan’s strengths in electronics and healthcare, challenges such as improving software and aligning regulatory standards with global norms remain. As AI becomes integral to healthcare, addressing these issues will be crucial for Taiwan’s MedTech competitiveness.
At the 2024 U.S.-Taiwan Patient Day Innovation Forum, Shih Chung-liang from NHIA emphasized the benefits of transcatheter aortic valve implantation (TAVI), noting its less invasive nature and faster recovery compared to traditional surgery. As Taiwan’s population ages, the demand for TAVI is expected to rise, with Edwards Lifesciences leading advancements in this transformative technology.
Hoping to increase competitiveness and improve patient outcomes, Taiwan’s hospitals are investing in high-value medical devices and artificial intelligence. But finding a balance between state-of-the-art equipment and affordable services remains a challenge. Despite continuous increases in the National Health Insurance (NHI) budget and raised premiums, Taiwan’s hospitals face progressively strained finances and stiff competition. To…
While Taiwan has seen a surge in the adoption of telemedicine in recent months, its utilization rate of home-based dialysis is less than half that of the Asia Pacific average. The COVID-19 pandemic has accelerated the digitalization of healthcare and increased the market for telemedicine. As a result of capacity-saving efforts and swift innovation during…
Becton Dickinson and Company (BD), founded in 1897, is a global medical technology company that has more than 65,000 employees in 50 countries. BD has a well-established reputation in the industry for patient and healthcare worker safety and improving medical research and clinical laboratories. The company provides innovative solutions that help advance genomics, enhance the…
As Taiwan society ages, this challenging condition is becoming more prevalent. With the rapid rise in the proportion of elderly people in the Taiwan population, one of the medical conditions that will require increased attention is osteoporosis. A progressive skeletal disease characterized by decreased bone density and weakened bone tissue, osteoporosis frequently leads to falls…
As 2019 draws to a close without the achievement of several hoped-for advances in regulatory procedures for medical devices, multinational companies in the sector are looking to the new year for some significant breakthroughs. Topping the wish list is passage of the draft Medical Devices Act, which would create dedicated legislation to govern the industry…
The Taiwan Precision Medicine Initiative offers the opportunity to dramatically improve the nation’s medical landscape and advance the lucrative biomedical sector with an ambitious DNA mapping project. “The best doctor cures the illness that is still obscure, the good doctor cures the illness that is about to break out, and the ordinary doctor treats the…
Taiwan and other regional players are finding it difficult to compete on the same scale as China when it comes to hosting clinical trials. Over the years, Taiwan has developed a strong reputation in the field of healthcare. It is now looking to leverage its advantages to position itself as a regional biomedical hub and…
